Human recombinant EGF protein delivered by a biodegradable cell transplantation system

Tissue Eng. 2002 Apr;8(2):263-72. doi: 10.1089/107632702753725021.

Abstract

We have previously shown a new approach to expand cultured human keratinocytes and reconstitute the epidermis in full-thickness wounds using a new microsperical transport system. This was a new approach to increase the cell yield for seeding without altering the anchoring proteins by enzymatic steps. That time we used Cytodex 3 which failed to be degraded and induced an inflammatory reaction in a t-cell-deficient organism. Therefore, we have investigated another microcarrier consisting of PLGA, which is a well-known carrier material for cell culture and transplantation. After coating the PLGA carrier with gelatine the seeding time of viable cells reached 4 h and the cell gain after 7 days of spinner culture was 16-fold. At 14 days after transplantation, we could detect a new stratified epithelium in our full-thickness wound healing model. Because cytokines play a major role in wound healing, we loaded this carrier material with different concentrations of rhEGF, showing a dose dependent release of the protein in vitro and in vivo. This result might lead to a different approach in the treatment of wounds.

Publication types

  • Comparative Study

MeSH terms

  • Absorbable Implants*
  • Adult
  • Animals
  • Biocompatible Materials
  • Cell Transplantation / methods*
  • Drug Carriers
  • Drug Delivery Systems*
  • Epidermal Growth Factor / administration & dosage*
  • Humans
  • Keratinocytes / cytology*
  • Keratinocytes / drug effects*
  • Lactic Acid
  • Mice
  • Mice, Nude
  • Polyglycolic Acid
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polymers
  • Recombinant Proteins / administration & dosage
  • Wound Healing / drug effects

Substances

  • Biocompatible Materials
  • Drug Carriers
  • Polymers
  • Recombinant Proteins
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid
  • Epidermal Growth Factor